Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2007 1
2008 3
2010 1
2011 2
2012 3
2013 3
2014 8
2015 4
2016 2
2017 4
2019 2
2020 2
2021 5
2022 6
2023 2
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
Armstrong E, Hemmerling A, Miller S, Huibner S, Kulikova M, Liu R, Crawford E, Castañeda GR, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Among authors: huibner s. Microbiol Spectr. 2024 Aug 6;12(8):e0350123. doi: 10.1128/spectrum.03501-23. Epub 2024 Jun 24. Microbiol Spectr. 2024. PMID: 38912808 Free PMC article. Clinical Trial.
Soluble E-cadherin: A marker of genital epithelial disruption.
Liu R, Armstrong E, Constable S, Buchanan LB, Mohammadi A, Galiwango RM, Huibner S, Perry MC, Prodger JL, Coburn B, Kaul R. Liu R, et al. Among authors: huibner s. Am J Reprod Immunol. 2023 Mar;89(3):e13674. doi: 10.1111/aji.13674. Epub 2023 Jan 12. Am J Reprod Immunol. 2023. PMID: 36593681
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Among authors: huibner s. Lancet Microbe. 2022 Jun;3(6):e435-e442. doi: 10.1016/S2666-5247(22)00043-X. Epub 2022 Apr 21. Lancet Microbe. 2022. PMID: 35659905 Free PMC article. Clinical Trial.
Impact of antimicrobials on penile HIV susceptibility and immunology in uncircumcised men: A randomized phase 1/2 clinical trial.
Galiwango RM, Okech B, Park DE, Buchanan L, Shao Z, Bagaya B, Mpendo J, Joag V, Yegorov S, Nanvubya A, Biribawa VM, Namatovu T, Kato C, Kawoozo B, Ssetaala A, Muwanga M, Aziz M, Pham T, Huibner S, Tobian AAR, Liu CM, Prodger JL, Kaul R. Galiwango RM, et al. Among authors: huibner s. Cell Rep Med. 2024 Sep 17;5(9):101705. doi: 10.1016/j.xcrm.2024.101705. Epub 2024 Aug 29. Cell Rep Med. 2024. PMID: 39214083 Free PMC article. Clinical Trial.
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Liu R, Crawford ED, Castañeda GR, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Among authors: huibner s. J Clin Invest. 2022 Mar 15;132(6):e152930. doi: 10.1172/JCI152930. J Clin Invest. 2022. PMID: 35113809 Free PMC article. Clinical Trial.
Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4+ T Cell Recovery.
Rousseau RK, Walmsley SL, Lee T, Rosenes R, Reinhard RJ, Malazogu F, Benko E, Huibner S, Kovacs CM, Singer J, Kim CJ, Kaul R. Rousseau RK, et al. Among authors: huibner s. J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):199-207. doi: 10.1097/QAI.0000000000002840. J Acquir Immune Defic Syndr. 2022. PMID: 34693932 Clinical Trial.
52 results